Location History:
- Elmsford, NY (US) (2021 - 2024)
- Greenwich, CT (US) (2024)
Company Filing History:
Years Active: 2021-2025
Title: Ankit Vartak: Innovator in Anti-VEGF Protein Compositions
Introduction
Ankit Vartak is a prominent inventor based in Elmsford, NY (US), known for his significant contributions to the field of biotechnology. With a total of 15 patents to his name, he has made remarkable advancements in the development of anti-VEGF protein compositions.
Latest Patents
His latest patents include innovative compositions comprising aflibercept and methods for producing these compositions in chemically defined media. These methods utilize chromatography to reduce certain aflibercept variants, showcasing his expertise in protein engineering. Additionally, he has developed compositions comprising anti-VEGF proteins, further emphasizing his focus on therapeutic solutions in the medical field.
Career Highlights
Ankit has worked with notable companies such as Regeneron Pharmaceuticals, Inc. and Regeneran Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the biotechnology sector.
Collaborations
Throughout his career, Ankit has collaborated with talented individuals, including Andrew Tustian and Thomas Daly. These partnerships have played a crucial role in advancing his research and patent developments.
Conclusion
Ankit Vartak's innovative work in anti-VEGF protein compositions highlights his significant impact on biotechnology. His contributions continue to pave the way for advancements in therapeutic solutions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.